Gene Ontology analysis indicated that Nrf2 deficiency enhanced the expression of genes associated with immune responses (Figure S5A) or T cell activation-associated pathways (Figure S5B), consistent with our observation that Nrf2−/− CD8+ T cells improved tumor lysis and cytokine productivity. The gene discussed is CD8A; the disease is neoplasm.